HOME >> BIOLOGY >> NEWS
Marijuana use could cause tubal pregnancies

Marijuana use may increase the risk of ectopic (tubal) pregnancies, researchers at Vanderbilt University Medical Center reported this week.

The researchers studied CB1, a "cannabinoid" receptor that binds the main active chemical for marijuana, delta-9-tetrahydrocannabinol (THC).

In pregnant mice that lacked the gene for the receptor, or in which the receptor was blocked, the embryo failed to go through the oviduct the tube leading from the ovaries to the uterus. The same thing happened in normal mice when the receptor was over-stimulated.

The study, published in the current issue of the journal Nature Medicine, describes for the first time how the CB1 receptor in the mouse regulates muscle contraction to move the embryo down the oviduct.

It is not known whether drugs that block or, in the case of marijuana, over-stimulate the CB1 receptor can cause ectopic pregnancy in humans. However, "our results raise caution for women of reproductive ages regarding the chronic use of marijuana for recreation or pain alleviation," the researchers concluded.

The report's senior author, Sudhansu K. Dey, Ph.D., said he also was concerned about the potential impact of an anti-obesity drug, now in clinical trials, that suppresses appetite by blocking the CB1 receptor. Such a drug, if approved, would likely be taken by young women of reproductive age.

"What will happen if they consume anti-CB1 drugs?" asked Dey, Dorothy Overall Wells Professor of Pediatrics and professor of Cell & Developmental Biology and Pharmacology at Vanderbilt University Medical Center.

According to the U.S. Centers for Disease Control and Prevention, about 100,000 ectopic pregnancies occur in the United States each year (out of more than 6 million total pregnancies) and account for about 9 percent of all pregnancy-related deaths in the country. Risk factors include pelvic inflammatory disease, which can scar the fallopian tubes, and smoking.

At the same time, s
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
27-Sep-2004


Page: 1 2 3

Related biology news :

1. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
2. Marijuana receptor gene abnormality in schizophrenia
3. Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure
4. Circulation of disaster myths in Haiti could hinder appropriate disposal of bodies
5. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
6. Gene chips research in cotton could lead to superior variety
7. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
8. Bullish chemical could repel yellow fever mosquitoes
9. Termites could hold the key to self-sufficient buildings
10. Wastewater could treat itself, power city
11. Sugar-coated sea urchin eggs could have sweet implications for human fertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: